文献速递药物不良反应与药物警戒

对乙酰氨基酚与Stevens-Johnson综合征及中毒性表皮坏死松解症风险:法国药物警戒数据库分析

Is acetaminophen associated with a risk of Stevens-Johnson syndrome and toxic epidermal necrolysis? Analysis of the French Pharmacovigilance Database.
PubMed 文献 · Br J Clin Pharmacol · 2017-11-10

本研究基于法国药物警戒数据库2002年1月至2013年12月的数据,由专家组分析了对乙酰氨基酚作为可疑药物导致SJS/TEN的病例,并使用ALDEN算法评估因果关系。共纳入112例病例(47例TEN、51例SJS、14例重叠),涉及574种可疑药物。结果表明,在这一大型国家系列中未发现对乙酰氨基酚使用与SJS/TEN风险存在明显关联。

要点

  • 对乙酰氨基酚作为可疑药物致SJS/TEN的112例中,多数因果关系评分不高于其他药物。
  • 仅20例对乙酰氨基酚因果关系为「可能」或「很可能」,其中14例存在原发病偏倚或混杂偏倚。
  • 基于法国药物警戒数据库的分析未发现对乙酰氨基酚与SJS/TEN的明显风险关联。

核心结论

  • 基于法国药物警戒数据库使用ALDEN算法分析,未发现对乙酰氨基酚使用与SJS/TEN存在明显风险关联。

研究设计与样本

  • 回顾性研究,分析法国药物警戒数据库2002年1月至2013年12月登记的SJS/TEN病例,由专家组评估对乙酰氨基酚作为可疑药物的因果关系,并以ALDEN算法为参考工具。

主要发现

  • 80例中对乙酰氨基酚的ALDEN评分低于或等于其他药物,其他药物因果关系嫌疑更高。
  • 32例中对乙酰氨基酚评分最高,但其中12例因果关系为「非常不可能」或「不可能」。
  • 剩余20例因果关系为「可能」或「很可能」,其中14例可能存在原发病偏倚或混杂偏倚。

临床怎么用

  • 临床遇到SJS/TEN病例时,应综合评估所有可疑药物,不应仅因使用对乙酰氨基酚即归因。
  • 对乙酰氨基酚作为可疑药物时,需注意原发病或混杂因素对因果关系判断的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but severe mostly drug-induced cutaneous reactions. Acetaminophen is an over-the-counter drug used worldwide to treat pain and reduce fever. In 2013, the US Food and Drug Administration informed the public that acetaminophen was associated with a rare risk of SJS/TEN. The aim of the present retrospective study was to analyse reports of acetaminophen as a possible suspect in the development of SJS/TEN from the French Pharmacovigilance Database (FPDB). METHODS: Cases of TEN/SJS with acetaminophen as a suspect drug registered in the FPDB, collected from January 2002 to December 2013, were analysed by an expert group. The algorithm of drug causality for epidermal necrolysis (ALDEN) was used as a reference tool for SJS/TEN to assess the causality of each suspect drug. RESULTS: After exclusion of 16 nonvalidated cases, 112 cases (47 TEN, 51 SJS, 14 SJS/TEN overlaps) involving 574 suspected drugs (5⋅1/case) were analysed. In 80 cases, the acetaminophen ALDEN score was inferior or equal to that of other drugs, associated with a higher suspicion for causality. In 32 cases, acetaminophen had the highest score but matched with a 'very unlikely' or 'unlikely' causality in 12 cases. For the 20 remaining cases with a 'possible' or ' probable' causality, a protopathic or a confounding bias was likely in 14 cases. CONCLUSIONS: After analysis of the French pharmacovigilance data using the ALDEN algorithm, we found no obvious SJS/TEN risk related to the use of acetaminophen in this large national series.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Lebrun-Vignes B, Guy C, Jean-Pastor MJ, et al. Is acetaminophen associated with a risk of Stevens-Johnson syndrome and toxic epidermal necrolysis? Analysis of the French Pharmacovigilance Database. Br J Clin Pharmacol. 2017. PMID: 28963996. doi:10.1111/bcp.13445

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。